The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis

Abstract Objectives The OPG/RANKL signal pathway was important regulation mechanism of bone remodeling cycle, but the effect of osteoprotegerin (OPG) and RANKL in osteoporosis was uncertain. We did a systematic review with meta-analysis to assess the association between serum OPG/RANKL and osteoporo...

Full description

Bibliographic Details
Main Authors:	Guanghao Chi, Longshun Qiu, Jian Ma, Wei Wu, Yuxin Zhang
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	Journal of Orthopaedic Surgery and Research
Subjects:	Osteoporosis Bone turnover Osteoprotegerin RANKL Meta-analysis
Online Access:	https://doi.org/10.1186/s13018-023-04179-5

Similar Items

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study
by: Osama E. Amer, et al.
Published: (2022-07-01)

RANK, RANKL and osteoprotegerin in arthritic bone loss
by: M.C. Bezerra, et al.
Published: (2005-02-01)

Functionalized calcium phosphate nanoparticles to direct osteoprotegerin to bone lesion sites in a medaka (Oryzias latipes) osteoporosis model
by: Nurgul Imangali, et al.
Published: (2023-02-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
by: Riham Eid, et al.
Published: (2023-06-01)

Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status
by: Ginka Delcheva, et al.
Published: (2023-03-01)

Vertebral marrow fat fraction is associated with circulating RANKL in postmenopausal females
by: Xuefeng Li, et al.
Published: (2024-09-01)

Protection against Osteoporosis by Fermented Mulberry Vinegar Supplementation via Inhibiting Osteoclastic Activity in Ovariectomized Rats and Osteoclastic Cells
by: Eun Jung Yim, et al.
Published: (2022-05-01)

Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway
by: Jose L. Fernandez‐Luna, et al.
Published: (2024-05-01)

Polylactic/polyglycolic acid copolymer is a good carrier for BMP-2 on bone regeneration?
by: Alexandre Ladeira Veloso dos Anjos, et al.
Published: (2017-05-01)

Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women – a pilot study
by: Selma Cvijetic, et al.
Published: (2016-03-01)

Pathogenetic and diagnostic role of osteoprotegerin in the combined course of osteoarthritis and obesity
by: A. Litvynova, et al.
Published: (2022-05-01)

Oligomeric proanthocyanidins ameliorates osteoclastogenesis through reducing OPG/RANKL ratio in chicken's embryos
by: Gengsheng Yu, et al.
Published: (2024-06-01)

Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
by: Xiao-Feng He, et al.
Published: (2017-11-01)

Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
by: Zhao Y, et al.
Published: (2020-01-01)

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
by: Chia-Wen Lu, et al.
Published: (2021-07-01)

The effect of osteoprotegerin on implant osseointegration in ovariectomized rats
by: Yiming Liu, et al.
Published: (2017-01-01)

Diabetes and consolidation of fractures
Published: (2013-06-01)

<it>Eurycoma longifolia</it> upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model
by: Shuid Ahmad, et al.
Published: (2012-09-01)

Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
by: Filip Przerwa, et al.
Published: (2023-12-01)

The levels of osteoprotegerin, transforming growth factor-β, and some cytokines in women with coronary heart disease concurrent with severe osteoporosis
by: S Yu Tsarenok, et al.
Published: (2015-09-01)

Association between osteoprotegerin and RANKL single nucleotide polymorphisms and destructive rhinosinusitis in patients with granulomatosis with polyangiitis
by: Marília A. D. Furquim, et al.
Published: (2024-11-01)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
by: Michalis Spartalis, et al.
Published: (2023-02-01)

Mechanism of Acupuncture Therapy on RANKL/OPG Signaling Pathway to Regulate Bone Metabolism Balance in Osteoporosis Model Rats
by: Qin YIN, et al.
Published: (2021-08-01)

Gestational protein restriction alters the RANKL/OPG system in the dental germ of offsprings
by: Bruno Calsa, et al.
Published: (2020-10-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
by: Salvador Atilano-Miguel, et al.
Published: (2022-01-01)

Diagnostic potential of salivary interleukin‐17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case‐control study
by: Marwa A. Abdullameer, et al.
Published: (2023-02-01)

Mechanism of Bushen Huoxue Recipe on Improving Arterial Calcification in Rats with Osteoporosis Based on OPG/RANKL Signaling Pathway
by: LIN Xiaorong, et al.
Published: (2022-08-01)

STUDY REGARDING THE QUANTIFICATION OF RANKL LEVELS IN PATIENTS WITH CHRONIC PERIODONTITIS AND OSTEOPOROSIS
by: Irina-Georgeta Șufaru, et al.
Published: (2017-01-01)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
by: Aleksandra Jawiarczyk-Przybyłowska, et al.
Published: (2022-04-01)

Polymorphisms within RANKL and Osteoprotegerin Genes in Low Bone Mass among Postmenopausal Indonesian Women
by: Ignatio Rika Haryono, et al.
Published: (2019-04-01)

THE ROLE OF CYTOKINE SYSTEM RANKL-RANK-OPG AND CATHEPSIN K IN THE PATHOGENESIS OF OSTEOPOROSIS: ACHIEVEMENTS AND PERSPECTIVES IN THE TREATMENT OF DISEASE
by: S. Sagalovsky, et al.
Published: (2015-10-01)

OPG/RANKL/RANK cytokine system in renal osteodystrophy
by: Ivica Avberšek-Lužnik, et al.
Published: (2007-11-01)

Mechanistic Insights and Therapeutic Strategies in Osteoporosis: A Comprehensive Review
by: Nyruz Ramadan Elahmer, et al.
Published: (2024-07-01)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
by: Dured Dardari, et al.
Published: (2022-04-01)

The role of genetic and metabolic disorders in osteoporosis
by: L. V. Vasilyeva, et al.
Published: (2021-03-01)

Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss
by: Xiaole Peng, et al.
Published: (2024-03-01)

Pdk3’s role in RANKL-induced osteoclast differentiation: insights from a bone marrow macrophage model
by: Nan Zhang, et al.
Published: (2024-10-01)